Back to comparisons

Comparison

Oxiracetam vs CDP-Choline

FieldOxiracetamCDP-Choline
Categoryracetamcholinergic
Dose range800–2400mg250–500mg
Half-life8h56h
Onset45min60min
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●
Legal (US)USUnscheduledUSOTC
PubMed refs150420

The comparison in plain English

Auto-generated from data

Oxiracetam and CDP-Choline are both in the racetam (racetam) and cholinergic respectively. Oxiracetam Water-soluble racetam known for analytical focus and logical reasoning enhancement. CDP-Choline Cytidine 5'-diphosphocholine.

Bottom line

Oxiracetam (evidence B, safety 4/5) has a stronger evidence base than CDP-Choline (evidence A, safety 5/5). CDP-Choline has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Oxiracetam if

Oxiracetam is the better fit when your goal aligns with its mechanism (Modulates AMPA and NMDA receptors and stimulates release of excitatory neurotransmitters including glutamate and D-aspartate) and the dose range (800–2400mg) suits your protocol. Half-life is 8h.

Choose CDP-Choline if

CDP-Choline is the better fit when your goal aligns with its mechanism (Hydrolysed into choline and cytidine in the gut) and the dose range (250–500mg) suits your protocol. Half-life is 56h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →